Research
The UK government has announced a plan to diagnose 92 per cent of people with dementia within 18 weeks of a doctor’s referral by 2029 — up from fewer than half today. A £5m research challenge will fund new diagnostic tools, including blood tests, saliva analysis and AI-driven technologies, to speed up detection and improve [...]
US adults scored an average of 60 out of 100 on the new Longevity Preparedness Index (LPI), indicating that most are underprepared to live well as they age. The index measures readiness across eight areas: social connection, daily activities, care, home, community, life transitions, health and finance. Care preparedness scored lowest at 42, while community [...]
Czech company H₂ Medical Technologies, a subsidiary of H₂ Global Group, has received official approval from the State Institute for Drug Control (SÚKL) to begin a clinical study on molecular hydrogen inhalation therapy for patients with mild cognitive impairment (MCI), an early stage of Alzheimer’s disease. The authorisation marks Europe’s first fully approved clinical trial [...]
Canada has conditionally approved Leqembi (lecanemab), the first treatment that targets an underlying cause of early Alzheimer’s disease by removing toxic amyloid beta proteins from the brain. Health Canada issued the Notice of Compliance with Conditions on 27 October for adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease who have confirmed [...]
Swapping just 30 minutes of sitting for light activity, such as walking or housework, can improve mood and energy the following day, new research suggests. A study involving more than 350 young adults found that on days when participants spent less time sitting and more time doing light activity, they felt happier and more energised [...]
Bright light at night raises the risk of heart attack by 47 per cent and heart failure by 56 per cent, according to research involving nearly 89,000 people. Being exposed to bright light at night could significantly increase the chances of developing serious heart problems, including heart attacks, strokes and heart failure. The largest study [...]
Semaglutide reduces the risk of heart attack and stroke by 20 per cent, regardless of weight lost, according to the largest study of 17,604 patients. The drug, the main ingredient in Wegovy, reduced the risk of major adverse cardiac events — including deaths from heart disease, heart attacks or strokes — by 20 per cent, [...]
Researchers have shown that new TOR inhibitor rapalink-1 prolongs lifespan in fission yeast, offering insight into how drugs may slow ageing. Rapalink-1, a next-generation TOR inhibitor currently under investigation for cancer therapy, slowed cell growth and significantly extended lifespan in yeast models, acting through TORC1 — the growth-promoting arm of the TOR pathway. The TOR [...]
Researchers in Denmark have discovered why the APOE4 gene increases Alzheimer’s risk — by preventing brain cells from switching from glucose to fats for energy as they age. The study found that as brain cells grow older and lose efficiency in using glucose — their main energy source — they can normally switch to burning [...]
Nearly half of 18 to 24-year-olds in the UK fear developing dementia, compared with just over a third of those aged over 65, new research has found. The study, commissioned by Bluebird Care, found that 45 per cent of those aged 18 to 24 expressed concern about developing the condition. This makes them the most [...]
